Menderes Akdag Sells 6,274 Shares of PetMed Express Inc. (PETS) Stock
PetMed Express Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 6,274 shares of the firm’s stock in a transaction that occurred on Friday, November 25th. The stock was sold at an average price of $22.25, for a total value of $139,596.50. Following the sale, the chief executive officer now directly owns 550,000 shares of the company’s stock, valued at approximately $12,237,500. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Menderes Akdag also recently made the following trade(s):
- On Monday, November 14th, Menderes Akdag sold 40,000 shares of PetMed Express stock. The stock was sold at an average price of $21.63, for a total value of $865,200.00.
- On Monday, October 10th, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $21.00, for a total value of $210,000.00.
- On Thursday, September 22nd, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $20.75, for a total value of $207,500.00.
PetMed Express Inc. (NASDAQ:PETS) opened at 21.83 on Thursday. The stock has a 50 day moving average price of $20.66 and a 200-day moving average price of $19.92. The company has a market cap of $442.12 million, a price-to-earnings ratio of 20.40 and a beta of 1.11. PetMed Express Inc. has a 12-month low of $15.73 and a 12-month high of $22.37.
PetMed Express (NASDAQ:PETS) last released its earnings results on Monday, October 24th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by $0.02. PetMed Express had a net margin of 9.10% and a return on equity of 25.77%. The company earned $60.80 million during the quarter, compared to the consensus estimate of $58.47 million. During the same period last year, the firm posted $0.22 EPS. The company’s revenue was up 7.2% on a year-over-year basis. On average, analysts predict that PetMed Express Inc. will post $1.09 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, November 18th. Stockholders of record on Monday, November 7th were paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 3.48%. The ex-dividend date of this dividend was Thursday, November 3rd. PetMed Express’s dividend payout ratio (DPR) is presently 71.03%.
Several large investors have recently added to or reduced their stakes in PETS. NEXT Financial Group Inc increased its position in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock worth $100,000 after buying an additional 3,350 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in shares of PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock worth $116,000 after buying an additional 3,121 shares in the last quarter. Royal Bank of Canada increased its position in shares of PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock worth $120,000 after buying an additional 1,053 shares in the last quarter. Cutler Group LP increased its position in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock worth $132,000 after buying an additional 8,029 shares in the last quarter. Finally, Bank of Montreal Can acquired a new position in shares of PetMed Express during the second quarter worth about $143,000. 73.97% of the stock is owned by institutional investors.
Several brokerages have issued reports on PETS. Zacks Investment Research lowered PetMed Express from a “hold” rating to a “sell” rating in a report on Thursday, October 27th. Credit Suisse Group AG reiterated a “sell” rating and issued a $13.00 price target on shares of PetMed Express in a report on Tuesday, August 16th.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.